Join this webinar to find out how we can help accelerate your Drug Discovery! our first speaker will provide an overview of these approaches, followed by a case study on anti-obesity drug development presented by our second speaker.
Join this webinar to find out how we can help accelerate your Drug Discovery! This webinar will provide three key technologies relevant to NAMs. These technologies can be introduced prior to IND or clinical studies.
Join this webinar to find out how we can help accelerate your Drug Discovery! In this seminar, we will introduce how we are tackling the challenge to create candidate compounds for new chemical modalities.
Join this webinar to find out how we can help accelerate your Targeted Protein Degradation Drug Discovery! In this webinar, we will introduce our "DegLead Platform™," an integrated TPD platform, and showcase how our strengths—including specialized chemistry, a comprehensive compound library, diverse assay systems, and advanced ADME solutions—can drive success in your TPD projects. Additionally, we will share application case studies and valuable insights.
Join this webinar to find out how we can help accelerate your Targeted Protein Degradation Drug Discovery! In this webinar, we will introduce our "DegLead Platform™," an integrated TPD platform, and showcase how our strengths—including specialized chemistry, a comprehensive compound library, diverse assay systems, and advanced ADME solutions—can drive success in your TPD projects. Additionally, we will share application case studies and valuable insights.
Join this webinar to find out how we can help you identify promising novel leads! In this webinar, we will showcase our integrated HTS platform and share our successful track record. We will also highlight the latest advances powered by computational chemistry and AI/ML technologies.
A webinar co-hosted by Axcelead Drug Discovery Partners (ADDP), SEKISUI MEDICAL, and KRCC. The webinar is for Korean scientists. After the speech, the breakout meeting rooms are available, where our experts will answer your further and detailed questions.
High-throughput screening (HTS) is the key methodology to identify hit and lead compouds for drug discovery. The innovative technologies for drugging undruggable targets and IPS cells have been shed new light on small molecule drug discovery.
Mounting competitive pressure is forcing the biopharma industry to look at new ways to shorten the time scale for all aspects of drug discovery.
High-throughput screening (HTS) is the key methodology to identify hit and lead compouds for drug discovery. The innovative technologies for drugging undruggable targets and IPS cells have been shed new light on small molecule drug discovery.